Skip to content
PubMed This is a summary of 69 peer-reviewed journal articles Updated
Ophthalmology · Neurotrophic Keratitis

Neurotrophic Keratoconjunctivitis: A Patient Guide

At a Glance

Neurotrophic keratitis is a rare condition in which damaged corneal nerves reduce sensation and impair blinking, tears, and healing. Because the eye may not hurt, regular monitoring and early treatment are essential to prevent ulcers and vision loss.

Neurotrophic keratitis (NK)—sometimes called neurotrophic keratoconjunctivitis—is a rare degenerative condition that affects the cornea, the clear, protective window at the front of your eye. The health of your cornea is managed by the trigeminal nerve, which does much more than just provide sensation; it acts as a vital support system that signals the eye to blink, produce tears, and repair minor surface damage [1]. When this nerve is damaged, the cornea’s ability to maintain and heal itself is severely impaired, leading to a breakdown of the eye’s surface [2].

The defining challenge of this condition is a core paradox: the more the disease progresses, the less you may feel it. Because the sensory nerves are compromised, the eye’s natural “alarm system” is reduced or absent, allowing serious damage to occur without the sharp pain typically associated with eye injuries [1]. This “silent” progression makes the disease a significant threat to your vision, as you may not realize the surface of your eye is deteriorating until your sight begins to blur, the tissue becomes visibly cloudy, or a painless infection takes hold [3].

Physicians categorize the severity of the disease into three stages to guide treatment. It begins with epithelial alterations, where the top layer of the cornea becomes unstable and dry; progresses to persistent epithelial defects, where an open sore develops that refuses to heal; and can eventually lead to stromal ulceration or “melting,” where the deeper layers of the cornea are at risk [1][4]. Because these stages move toward increasing fragility, early recognition and intervention are the most effective ways to preserve long-term vision [5].

Managing this condition requires a proactive partnership with a cornea specialist who understands the unique needs of a “numb” eye. Treatment strategies focus on restoring the protective environment the eye can no longer provide for itself, ranging from the use of specialized preservative-free lubricants to advanced therapies like nerve growth factor drops or surgical interventions to reinforce the corneal structure [6][7]. While a diagnosis can feel overwhelming, a dedicated care plan can help stabilize the eye and support the vital biological processes necessary to keep your vision clear [8].

Common questions in this guide

What is neurotrophic keratitis, and why can it be painless?
Neurotrophic keratitis, also called neurotrophic keratoconjunctivitis, occurs when damage to the nerves that support the cornea reduces sensation and impairs blinking, tears, and healing. Because the eye’s warning signals are weakened, serious surface damage can develop with little or no pain.
What are the three stages of neurotrophic keratitis?
Stage 1 involves changes in the cornea’s surface, including dryness and instability. Stage 2 is a persistent epithelial defect, meaning an open sore in the surface that does not heal. Stage 3 involves stromal ulceration or corneal melting, which threatens deeper tissue and vision.
What symptoms should I watch for if my cornea feels numb?
Watch for blurred vision, a cloudy-looking cornea, or other changes in the eye even when pain is absent. A painless infection or worsening surface damage can occur, so a lack of discomfort does not show that the eye is healthy.
How is neurotrophic keratitis treated?
Treatment aims to protect the cornea and support healing. Depending on the disease stage, a cornea specialist may recommend preservative-free lubricating drops, nerve growth factor drops, or surgery to reinforce the cornea.
Which health conditions may raise the risk of neurotrophic keratitis?
A history of herpes infection or diabetes may be relevant because these conditions can affect the nerves that support the cornea. Tell your eye specialist about these and any other nerve-related conditions so your risk can be assessed.
How often should I have my eye checked for neurotrophic keratitis?
Your cornea specialist should set a follow-up schedule based on your eye’s condition and disease stage. Regular examinations are important because neurotrophic keratitis can worsen without the pain that usually signals an eye problem.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that this is a 'silent' disease, how often should we be checking my eye surface to catch changes early?
  2. 2.Are you a cornea specialist with experience specifically in managing neurotrophic keratitis?
  3. 3.How do you determine which stage of the disease I am currently in?
  4. 4.What is our plan if the first-line treatments like preservative-free drops aren't enough to stabilize my eye?
  5. 5.Can you help me understand which of my current symptoms—or lack thereof—are the most important to track?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Neurotrophic keratitis: current challenges and future prospects.

    Versura P, Giannaccare G, Pellegrini M, et al.

    Eye and brain 2018; (10()):37-45 doi:10.2147/EB.S117261.

    PMID: 29988739
  2. 2

    Neurotrophic keratitis: inflammatory pathogenesis and novel therapies.

    Wajnsztajn D, Faraj LA, Sanchez-Tabernero S, Solomon A

    Current opinion in allergy and clinical immunology 2023; (23(6)):520-528 doi:10.1097/ACI.0000000000000942.

    PMID: 37694830
  3. 3

    [Clinical picture and diagnosis of neurotrophic keratopathy].

    Messmer EM

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2019; (116(2)):120-126 doi:10.1007/s00347-018-0822-x.

    PMID: 30535856
  4. 4

    Neurotrophic keratopathy: current challenges and future prospects.

    NaPier E, Camacho M, McDevitt TF, Sweeney AR

    Annals of medicine 2022; (54(1)):666-673 doi:10.1080/07853890.2022.2045035.

    PMID: 35243932
  5. 5

    Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.

    Dana R, Farid M, Gupta PK, et al.

    BMC ophthalmology 2021; (21(1)):327 doi:10.1186/s12886-021-02092-1.

    PMID: 34493256
  6. 6

    Neurotrophic Keratopathy: Current Concepts, Management, and Emerging Treatments.

    Cheung AY, Holland EJ

    Cornea 2026; (45(6)):673-685 doi:10.1097/ICO.0000000000004055.

    PMID: 42085714
  7. 7

    Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.

    Bonini S, Lambiase A, Rama P, et al.

    Ophthalmology 2018; (125(9)):1332-1343 doi:10.1016/j.ophtha.2018.02.022.

    PMID: 29653858
  8. 8

    Neurotrophic keratopathy: An updated understanding.

    The ocular surface 2023; (30()):129-138 doi:10.1016/j.jtos.2023.09.001.

    PMID: 37666470

This overview of neurotrophic keratitis is for informational purposes and does not replace medical advice. A cornea specialist or ophthalmologist should assess your corneal sensation, disease stage, and treatment plan.

Get notified when new evidence is published on neurotrophic keratoconjunctivitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.